These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9274715)
1. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector. Wang Q; Greenburg G; Bunch D; Farson D; Finer MH Gene Ther; 1997 May; 4(5):393-400. PubMed ID: 9274715 [TBL] [Abstract][Full Text] [Related]
2. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement. Ji L; Bouvet M; Price RE; Roth JA; Fang B Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089 [TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII. Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775 [TBL] [Abstract][Full Text] [Related]
4. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors. Kuzmin AI; Galenko O; Eisensmith RC Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770 [TBL] [Abstract][Full Text] [Related]
5. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Wang Q; Jia XC; Finer MH Gene Ther; 1995 Dec; 2(10):775-83. PubMed ID: 8750018 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of CXCR4 gene expression in primary human endothelial cells following infection with E1(-)E4(+) adenovirus gene transfer vectors. Ramalingam R; Worgall S; Rafii S; Crystal RG Mol Ther; 2000 Oct; 2(4):381-6. PubMed ID: 11020354 [TBL] [Abstract][Full Text] [Related]
7. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host. Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802 [TBL] [Abstract][Full Text] [Related]
8. Differential influence of the E4 adenoviral genes on viral and cellular promoters. Grave L; Dreyer D; Dieterle A; Leroy P; Michou AI; Doderer C; Pavirani A; Lusky M; Mehtali M J Gene Med; 2000; 2(6):433-43. PubMed ID: 11199264 [TBL] [Abstract][Full Text] [Related]
9. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector. Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924 [TBL] [Abstract][Full Text] [Related]
10. Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products. Christ M; Louis B; Stoeckel F; Dieterle A; Grave L; Dreyer D; Kintz J; Ali Hadji D; Lusky M; Mehtali M Hum Gene Ther; 2000 Feb; 11(3):415-27. PubMed ID: 10697116 [TBL] [Abstract][Full Text] [Related]
11. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. Gao GP; Yang Y; Wilson JM J Virol; 1996 Dec; 70(12):8934-43. PubMed ID: 8971023 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Michou AI; Santoro L; Christ M; Julliard V; Pavirani A; Mehtali M Gene Ther; 1997 May; 4(5):473-82. PubMed ID: 9274725 [TBL] [Abstract][Full Text] [Related]
13. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector. Van Linthout S; Lusky M; Collen D; De Geest B Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424 [TBL] [Abstract][Full Text] [Related]
14. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein. Hodges BL; Serra D; Hu H; Begy CA; Chamberlain JS; Amalfitano A J Gene Med; 2000; 2(4):250-9. PubMed ID: 10953916 [TBL] [Abstract][Full Text] [Related]
15. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3. Gorziglia MI; Lapcevich C; Roy S; Kang Q; Kadan M; Wu V; Pechan P; Kaleko M J Virol; 1999 Jul; 73(7):6048-55. PubMed ID: 10364357 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. Lusky M; Christ M; Rittner K; Dieterle A; Dreyer D; Mourot B; Schultz H; Stoeckel F; Pavirani A; Mehtali M J Virol; 1998 Mar; 72(3):2022-32. PubMed ID: 9499056 [TBL] [Abstract][Full Text] [Related]
17. Direct comparison of hepatocyte-specific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer. Jacobs F; Snoeys J; Feng Y; Van Craeyveld E; Lievens J; Armentano D; Cheng SH; De Geest B Gene Ther; 2008 Apr; 15(8):594-603. PubMed ID: 18288213 [TBL] [Abstract][Full Text] [Related]
18. Complementation of a human adenovirus early region 4 deletion mutant in 293 cells using adenovirus-polylysine-DNA complexes. Scaria A; Curiel DT; Kay MA Gene Ther; 1995 Jun; 2(4):295-8. PubMed ID: 7552990 [TBL] [Abstract][Full Text] [Related]
19. Effects of adenovirus mediated gene transfer to mouse testis in vivo on spermatogenesis and next generation. Kojima Y; Sasaki S; Umemoto Y; Hashimoto Y; Hayashi Y; Kohri K J Urol; 2003 Nov; 170(5):2109-14. PubMed ID: 14532865 [TBL] [Abstract][Full Text] [Related]